We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+8.81%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$30.1B
AUM Growth
+$1.02B
Cap. Flow
-$1.16B
Cap. Flow %
-3.87%
Top 10 Hldgs %
22.79%
Holding
1,200
New
104
Increased
364
Reduced
497
Closed
122

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$50.1M
2
CSCO icon
Cisco
CSCO
+$39.1M
3
EW icon
Edwards Lifesciences
EW
+$38.9M
4
ETN icon
Eaton
ETN
+$37.7M
5
BAC icon
Bank of America
BAC
+$36.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$92.9M
2
TXN icon
Texas Instruments
TXN
+$67.4M
3
PFE icon
Pfizer
PFE
+$57.7M
4
FIS icon
Fidelity National Information Services
FIS
+$56.9M
5
TSLA icon
Tesla
TSLA
+$51.5M

Sector Composition

Rank Sector Weight
1 Technology 33.71%
2 Healthcare 19.22%
3 Consumer Discretionary 11.87%
4 Financials 8.66%
5 Industrials 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VICI icon
876
VICI Properties
VICI
$27.3B
$630K ﹤0.01%
20,034
-49,581
-71% -$1.59M
HBAN icon
877
Huntington Bancshares
HBAN
$33.9B
$629K ﹤0.01%
58,350
-49,342
-46% -$527K
NUVB icon
878
Nuvation Bio
NUVB
$2B
$628K ﹤0.01%
348,800
-22,800
-6% -$38.8K
AN icon
879
AutoNation
AN
$6.77B
$626K ﹤0.01%
+3,800
New +$527K
XPO icon
880
XPO
XPO
$20.9B
$625K ﹤0.01%
10,600
-95,149
-90% -$4.31M
SCLX icon
881
Scilex Holding
SCLX
$35.5M
$608K ﹤0.01%
3,119
CHRS icon
882
Coherus Oncology
CHRS
$205M
$608K ﹤0.01%
+142,400
New +$840K
TRUE
883
DELISTED
TrueCar
TRUE
$605K ﹤0.01%
267,825
DFS
884
DELISTED
Discover Financial Services
DFS
$600K ﹤0.01%
5,138
-26,002
-84% -$2.72M
SGMO
885
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$596K ﹤0.01%
+458,600
New +$627K
LOCO icon
886
El Pollo Loco
LOCO
$441M
$594K ﹤0.01%
67,708
BHC icon
887
Bausch Health
BHC
$2.12B
$593K ﹤0.01%
74,146
-102,300
-58% -$754K
SIRI icon
888
SiriusXM
SIRI
$9.97B
$589K ﹤0.01%
13,008
+308
+2% +$11.6K
NSTG
889
DELISTED
NanoString Technologies, Inc.
NSTG
$573K ﹤0.01%
+141,500
New +$1.04M
AGR
890
DELISTED
Avangrid, Inc.
AGR
$573K ﹤0.01%
15,200
-83,600
-85% -$3.28M
HZNP
891
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$564K ﹤0.01%
5,488
+1,116
+26% +$118K
VIV icon
892
Telefônica Brasil
VIV
$19B
$562K ﹤0.01%
61,609
CBT icon
893
Cabot Corp
CBT
$4.14B
$562K ﹤0.01%
8,400
-2,000
-19% -$142K
SHG icon
894
Shinhan Financial Group
SHG
$38.7B
$558K ﹤0.01%
21,419
CMTL icon
895
Comtech Telecommunications
CMTL
$42.8M
$544K ﹤0.01%
+59,482
New +$638K
AVY icon
896
Avery Dennison
AVY
$13B
$540K ﹤0.01%
3,144
-19,677
-86% -$3.36M
ALSN icon
897
Allison Transmission
ALSN
$10.2B
$531K ﹤0.01%
9,400
PBA icon
898
Pembina Pipeline
PBA
$27.5B
$520K ﹤0.01%
16,555
-788
-5% -$25.2K
LKQ icon
899
LKQ Corp
LKQ
$6.04B
$517K ﹤0.01%
8,866
+79
+0.9% +$4.39K
FMC icon
900
FMC
FMC
$1.44B
$506K ﹤0.01%
4,846
-12,733
-72% -$1.43M

Similar funds

Axa's Q2 2023 Portfolio in Review

As of Q2 2023, Axa held 1,200 positions worth $30.1B, up 3.5% from $29.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Axa withdrew a net $1.16B in Q2 2023, closing 122 positions and reducing 497 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $44.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in Lincoln Electric worth $19.9M.

  • Axa's largest Q2 2023 buy was Lincoln Electric: 100,054 shares worth $19.9M.
  • Axa added most to Intuit in Q2 2023, an estimated $50.1M increase.
  • Axa's biggest Q2 2023 reduction was Apple, cutting an estimated $92.9M.
  • Axa fully exited Vanguard S&P 500 ETF in Q2 2023, selling an estimated $44.8M.
  • Axa's ten largest holdings make up 23% of its $30.1B portfolio in Q2 2023.
  • Axa opened 104 new positions and closed 122 in Q2 2023.
  • Axa's portfolio value rose 3.5% quarter-over-quarter to $30.1B.

Based on Axa's 13F filing for Q2 2023, filed 14 Aug 2023.